Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Salvia BioElectronics
NCT06603558 · Chronic Migraine, Episodic Migraine, and more
NCT07103694 · Episodic Migraine, Chronic Migraine, and more
NCT06810505 · Chronic Migraine
NCT07018713 · Chronic Migraine
NCT07071506 · Migraine, Migraine With or Without Aura, and more
Genesis Research Services
Broadmeadow, New South Wales
Resolve Pain
Buderim, Queensland
ZAS Antwerpen, Campus Sint-Augustinus
Wilrijk, Antwerpen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions